Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

Also called NCT05329740

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 212 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05329740
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05329740. Randomized; double masking; primary purpose treatment. Start 2022-02-07 (actual); primary completion 2023-11-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)
Condition
Methylprednisolone
Condition
Glucocorticoid
Condition
Organ Dysfunction
Intervention (Drug)
Methylprednisolone Injection
Lead sponsor
Shanghai Zhongshan Hospital (class: other)

Record details

Record id
cardio:ct-nct05329740
Content hash
48fcbee17ac456a4e9fd48f27663b24e7f23ea2b0b958cc5264f2e3c8c93d7f4